(Q43269983)

17 November 2017

1 reference

title

Molecular imaging of solid tumors: exploiting the potential (English)

1 reference

17 November 2017

1

Wim J G Oyen

0 references

author name string

Wim J G Oyen

series ordinal

1

1 reference

17 November 2017

Winette T A van der Graaf

series ordinal

2

1 reference

17 November 2017

language of work or name

English

0 references

publication date

1 October 2009

1 reference

Nature Reviews Clinical Oncology

17 November 2017

number of pages

3

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

17 November 2017

volume

6

1 reference

17 November 2017

issue

10

1 reference

17 November 2017

page(s)

609-611

1 reference

Prospective multicentric randomized phase III study of imatinib in patients with advanced gastrointestinal stromal tumors comparing interruption versus continuation of treatment beyond 1 year: the French Sarcoma Group.

17 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.139

Acquired resistance to imatinib in gastrointestinal stromal tumours caused by multiple KIT mutations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.139

Beyond RECIST: molecular and functional imaging techniques for evaluation of response to targeted therapy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.139

Preoperative staging of non-small-cell lung cancer with positron-emission tomography

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.139

Positron-emission tomography in prognostic and therapeutic assessment of lung cancer: systematic review.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.139

FDG-PET for prediction of survival of patients with metastatic colorectal carcinoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.139

Preoperative [18F] FDG-PET after chemotherapy in locally advanced breast cancer: prognostic value as compared with histopathology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.139

Powerful prognostic stratification by [18F]fluorodeoxyglucose positron emission tomography in patients with metastatic breast cancer treated with high-dose chemotherapy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.139

The standardized uptake value for F-18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.139

Clinical impact of, and prognostic stratification by, F-18 FDG PET/CT in head and neck mucosal squamous cell carcinoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.139

Diagnostic and prognostic value of 18F-FDG PET/CT for patients with suspected recurrence from squamous cell carcinoma of the esophagus.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.139

Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.139

Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.139

PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.139

The lessons of GIST--PET and PET/CT: a new paradigm for imaging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.139

Early prediction of response to sunitinib after imatinib failure by 18F-fluorodeoxyglucose positron emission tomography in patients with gastrointestinal stromal tumor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.139

The perfect storm of overutilization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.139

18F-FLT PET does not discriminate between reactive and metastatic lymph nodes in primary head and neck cancer patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.139

Usefulness of 3'-[F-18]fluoro-3'-deoxythymidine with positron emission tomography in predicting breast cancer response to therapy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.139

Indium-111-labeled trastuzumab scintigraphy in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.139

111Indium-trastuzumab visualises myocardial human epidermal growth factor receptor 2 expression shortly after anthracycline treatment but not during heart failure: a clue to uncover the mechanisms of trastuzumab-related cardiotoxicity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.139

Comparison of integrin alphaVbeta3 expression and glucose metabolism in primary and metastatic lesions in cancer patients: a PET study using 18F-galacto-RGD and 18F-FDG.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.139

Imaging liver metastases of colorectal cancer patients with radiolabelled bevacizumab: Lack of correlation with VEGF-A expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.139

Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG.

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19787004

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The reverse side of the victory: flare up of symptoms after discontinuation of sunitinib or sorafenib in renal cell cancer patients. A report of three cases.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19787004

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRCLINONC.2009.139

1 reference

17 November 2017

1 reference